They suggested that the findings indicate a possibility that LTB4 might be dominating RvE1 in terms of BLT-1 binding, leading to impaired resolution of airway inflammation, and consequently contributing to the development of chronic airway inflammation. Here, LTB4R is linked to inflammatory response.